BioXcel Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
BioXcel Therapeutics, Inc. (BTAI) reported Interest Income (Expense), Nonoperating, Net of -$2.88 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2022-11-14
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2022-09-30 was -$2.88M, a 287800.00% decline year-over-year.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2021-09-30 was $1.00K.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2020-06-30 was $16.00K, a 90.24% decline year-over-year.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2020-03-31 was $85.00K, a 60.47% decline year-over-year.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2019 was $633.00K, a 8.53% decline from fiscal 2018.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2018 was $692.00K.
- BioXcel Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2017 was -$2.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$2.88M 10-Q · filed 2022-11-14 | -$4.25M 10-Q · filed 2022-11-14 | ||
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-14 | -$2.00K 10-Q · filed 2022-11-14 | ||
| 2020-06-30 | $16.00K 10-Q · filed 2020-08-14 | $101.00K 10-Q · filed 2020-08-14 | $239.00K derived: sum of 3 quarters · filed 2020-08-14 | $355.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $85.00K 10-Q · filed 2020-05-12 | $223.00K derived: sum of 2 quarters · filed 2020-05-12 | $339.00K derived: sum of 3 quarters · filed 2020-05-12 | $503.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $254.00K derived: sum of 2 quarters · filed 2020-03-09 | $418.00K derived: sum of 3 quarters · filed 2020-08-14 | $633.00K 10-K · filed 2020-03-09 |
| 2019-09-30 | $116.00K 10-Q · filed 2019-11-14 | $280.00K derived: sum of 2 quarters · filed 2020-08-14 | $495.00K 10-Q · filed 2019-11-14 | $733.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-06-30 | $164.00K 10-Q · filed 2020-08-14 | $379.00K 10-Q · filed 2020-08-14 | $617.00K derived: sum of 3 quarters · filed 2020-08-14 | $849.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $215.00K 10-Q · filed 2020-05-12 | $453.00K derived: sum of 2 quarters · filed 2020-05-12 | $685.00K derived: sum of 3 quarters · filed 2020-05-12 | $903.00K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $470.00K derived: sum of 2 quarters · filed 2020-03-09 | $688.00K derived: sum of 3 quarters · filed 2020-03-09 | $692.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $232.00K 10-Q · filed 2019-11-14 | $450.00K derived: sum of 2 quarters · filed 2019-11-14 | $454.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $218.00K 10-Q · filed 2019-08-06 | $222.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $4.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$2.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |